uk neqas for h&i scheme 1a - hla typing phenotyping


[PDF]uk neqas for h&i scheme 1a - hla typing phenotyping...

0 downloads 193 Views 39KB Size

UK NEQAS FOR H&I SCHEME 1A - HLA TYPING PHENOTYPING ASSESSMENT TYPING RESULTS OF SAMPLE 1A04/2014 DESPATCHED ON 25TH MARCH CONSENSUS HLA TYPE: HLA-A25, A32; B7, B58; Cw7, -; DR13, DR15; DQ6, DQ7 Assessment Lab No. HLA-A HLA-B HLA-Cw HLA-DR HLA-DQ 9 11 20 25 28 41 54 58 62 116 119 120 123 133 139 142 145 149 154 159 164 181 187 193 194 206 223 225 227 232 238 245 262 268 279 284 285 289 297 299

YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES

YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES YES

YES

YES

YES

YES YES

YES YES YES YES YES YES YES YES YES

YES YES YES

YES YES YES YES YES YES YES

YES YES YES YES YES YES YES

YES YES YES YES

YES YES YES YES

YES YES

YES YES

YES

YES

YES YES

YES YES

YES

YES

YES YES YES YES YES

YES YES YES YES

HLA-A

A

25 32 25 (10) 32 (19) 25 32 25 32 25 32 25 32 25 32 25 32 25 32 NT NT 25 32 25 32 25 32 25 32 25 32 25 32 25 32 25 32 25 32 25 32 25 32 25 32 25 32 25 32 25 32 25 32 25 (10) 32 (19) 25 (10) 32 25 32 25 32 25 32 25 32 25 32 25 32 25 32 25 32 25 32 25 32 25 32 25 32

PLEASE NOTE: NEXT DISTRIBUTION IS ON 03RD JUNE 2014

B

B

C

7 7 7 7 7 7 7 7 7 NT 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7

58 58 (17) 58 58 58 58 58 58 58 NT 58 58 58 58 (17) 58 57 58 58 58 58 58 58 58 58 58 58 58 (17) 58 (17) 58 58 58 58 58 58 58 58 58 58 58 58

7

7 7

7

7

7 7

C

DR

DR

DQ

DQ

13 13 (6) 13 13 13 13 13 13 13

15 15 (2) 15 15 15 15 15 15 15

6 6 (1) 6 6 6 6 6 6 6

7 (3) 7 7 7 7 7 7 7

13 13 13 13 13 13 13

15 2 15 15 15 15 15

6 1 6 6 6 6 6

7 7 7 7 (3) 7 7 7

13 13 13 NT

15 15 15 NT

6 6 6 NT

7 7 7 NT

13 13

15 15

6 6

7 7

13

15

6

3

13 13

15 15

6 6

7 7

13

15

6

7

13

15

6

7

13

15

7 7

Date received

Date tested

27-Mar 26-Mar 26-Mar 26-Mar 26-Mar 26-Mar 26-Mar 26-Mar 26-Mar 26-Mar 26-Mar 27-Mar 27-Mar 27-Mar 31-Mar 27-Mar 26-Mar 27-Mar 26-Mar 27-Mar 26-Mar 26-Mar 27-Mar 26-Mar 26-Mar 26-Mar 27-Mar 27-Mar 26-Mar 01-Apr 26-Mar 26-Mar 26-Mar 26-Mar 26-Mar 26-Mar 26-Mar 29-Mar 26-Mar 26-Mar

28-Mar 27-Mar 26-Mar 27-Mar 26-Mar 27-Mar 27-Mar 26-Mar 26-Mar 27-Mar 26-Mar 27-Mar 28-Mar 28-Mar 31-Mar 27-Mar 27-Mar 28-Mar 26-Mar 27-Mar 26-Mar 27-Mar 27-Mar 26-Mar 26-Mar 26-Mar 28-Mar 28-Mar 26-Mar 02-Apr 27-Mar 26-Mar 26-Mar 27-Mar 27-Mar 27-Mar 27-Mar 29-Mar 24-Mar 27-Mar

UK NEQAS FOR H&I SCHEME 1A - HLA TYPING PHENOTYPING ASSESSMENT TYPING RESULTS OF SAMPLE 1A04/2014 DESPATCHED ON 25TH MARCH CONSENSUS HLA TYPE: HLA-

Lab No. 9 11 20 25 28 41 54 58 62

Supplemental DNA typing performed using:

U

Viability % T B

PCR-SSP PCR-SSP PCR-SSP PCR-SSP PCR-SSP/SSO PCR-SSP PCR-SSP PCR-SSO

95 85 80 99

PCR-SSP PCR-SSP PCR-SSO PCR-SSO

90 85 97 99

50 95 100 90 98

PCR-SSP PCR-SSP PCR-SSP

T-cell viability 90 100

98 90

90

80

100

99 80

95 80 B-cell yield

PCR-SSO PCR-SSO PCR-SSP PCR-SSP

100 99 95

99

99

100 95

PCR-SSO PCR-SSO PCR-SSP

90

PCR-SSO PCR-SSO PCR-SSO CDC PCR-SSO

98 80

90 95 100 95 85 100 90 100 98 80

90 40 90 90 98 80

Tray Manufacturer

Comments

One Lambda One Lambda One Lambda Innotrain Immunocor/Innotrain/Biotest One Lambda One Lambda Innotrain/One Lambda

>90 >80 95 90

NT 116 119 120 123 133 139 142 145 149 154 159 164 181 187 193 194 206 223 225 227 232 238 245 262 268 279 284 285 289 297 299

Testing failures

BioRad

There were too many cells on the vial. The sample had turned yellow and the viability was too low for typing

BioRad/One Lambda Ingen/One Lambda One Lambda BioRad One Lambda BioRad BioRad/Innotrain Biotest One Lambda One Lambda One Lambda One Lambda One Lambda Ingen/One Lambda One Lambda One Lambda BioRad BioRad One Lambda BioRad One Lambda One Lambda One Lambda One Lambda BioRad/BAG One Lambda One Lambda Ingen BAG

© Copyright Notice: Reports are confidential, and no data may be published without permission from UK NEQAS for H&I